omics

Improving clinical care is at the heart of the Craniofacial Program, designated as a new Frontier Program at CHOP.

The new CHOP Biobank has the potential to drive omics-based translational research, which can be transformative for pediatric healthcare.

These six stories received the highest number of engagements on CHOP Research social media channels in 2023.

Ingo Helbig, MD, discusses the Arcus Omics Data launch at CHOP in a Q&A.

The peptide-centric CAR T cells, or PC-CARS, target cancer drivers in tumor cells previously thought unreachable.